Diagnostics & Research
The Diagnostics & Research industry has a total of 45 stocks, with a combined market cap of $757.5 billion, total revenue of $168.76 billion and a weighted average PE ratio of 43.30.
Market Cap
757.5B
Revenue
168.76B
Profits
17.49B
PE Ratio
43.30
Profit Margin
10.37%
Dividend Yield
0.22%
45 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 194.52B | 1.97% | 2,321,760 | 45.20B |
| 2 | DHR | Danaher Corporation | 140.09B | 2.17% | 4,035,505 | 24.78B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 44.00B | 3.76% | 813,895 | 4.45B |
| 4 | NTRA | Natera, Inc. | 40.00B | 1.10% | 1,273,866 | 2.50B |
| 5 | WAT | Waters Corporation | 37.24B | 0.31% | 749,043 | 3.77B |
| 6 | A | Agilent Technologies, Inc. | 36.91B | -2.02% | 2,194,238 | 7.23B |
| 7 | IQV | IQVIA Holdings Inc. | 34.55B | 1.89% | 1,229,469 | 16.63B |
| 8 | ILMN | Illumina, Inc. | 28.55B | 2.60% | 2,941,434 | 4.39B |
| 9 | MTD | Mettler-Toledo International Inc. | 26.44B | 0.62% | 177,494 | 4.09B |
| 10 | DGX | Quest Diagnostics Incorporated | 23.88B | -0.14% | 869,666 | 11.28B |
| 11 | LH | Labcorp Holdings Inc. | 23.53B | 1.09% | 633,027 | 14.14B |
| 12 | GH | Guardant Health, Inc. | 22.27B | -1.63% | 3,447,575 | 1.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 15.92B | 2.20% | 356,558 | 2.68B |
| 14 | ICLR | ICON Public Limited Company | 13.26B | -1.14% | 938,189 | 8.27B |
| 15 | RVTY | Revvity, Inc. | 12.69B | 0.82% | 972,331 | 2.90B |
| 16 | CRL | Charles River Laboratories International, Inc. | 11.11B | 0.70% | 845,345 | 4.03B |
| 17 | QGEN | Qiagen N.V. | 8.29B | 2.48% | 1,625,900 | 2.10B |
| 18 | TWST | Twist Bioscience Corporation | 6.18B | -2.94% | 1,523,938 | 409.48M |
| 19 | BLLN | BillionToOne, Inc. | 5.54B | -1.62% | 611,541 | 354.54M |
| 20 | RDNT | RadNet, Inc. | 5.41B | 4.77% | 1,693,572 | 2.14B |
| 21 | SHC | Sotera Health Company | 5.11B | 1.01% | 3,085,191 | 1.19B |
| 22 | VCYT | Veracyte, Inc. | 4.55B | -4.63% | 1,149,997 | 541.74M |
| 23 | ADPT | Adaptive Biotechnologies Corporation | 3.39B | -5.27% | 3,470,889 | 295.41M |
| 24 | GRAL | GRAIL, Inc. | 2.97B | 1.47% | 337,734 | 156.12M |
| 25 | WGS | GeneDx Holdings Corp. | 2.00B | -5.86% | 925,814 | 442.68M |
| 26 | NEO | NeoGenomics, Inc. | 1.97B | 1.27% | 2,178,943 | 745.97M |
| 27 | CDNA | CareDx, Inc. | 1.51B | -0.21% | 855,779 | 412.82M |
| 28 | PSNL | Personalis, Inc. | 1.43B | -1.23% | 3,788,091 | 64.52M |
| 29 | OPK | OPKO Health, Inc. | 1.15B | -0.65% | 2,156,200 | 581.12M |
| 30 | CSTL | Castle Biosciences, Inc. | 731.26M | -2.43% | 175,502 | 339.92M |
| 31 | FLGT | Fulgent Genetics, Inc. | 592.15M | 0.14% | 184,268 | 320.35M |
| 32 | MYGN | Myriad Genetics, Inc. | 565.74M | -0.25% | 1,224,483 | 829.00M |
| 33 | BDSX | Biodesix, Inc. | 222.29M | -10.24% | 62,605 | 96.10M |
| 34 | IMDX | Insight Molecular Diagnostics Inc. | 185.35M | 0.88% | 142,045 | 1.95M |
| 35 | XGN | Exagen Inc. | 109.69M | -3.08% | 127,798 | 68.38M |
| 36 | BNR | Burning Rock Biotech Limited | 103.57M | 9.60% | 29,410 | 74.58M |
| 37 | PRPO | Precipio, Inc. | 45.15M | 0.72% | 6,893 | 25.83M |
| 38 | MDXH | MDxHealth SA | 24.48M | -6.02% | 949,201 | 110.97M |
| 39 | QUCY | Quantum Cyber N.V. | 21.26M | -5.84% | 1,217,622 | 537.08K |
| 40 | XWEL | XWELL, Inc. | 9.04M | 0.94% | 24,752 | 28.83M |
| 41 | MBAI | Check-Cap Ltd. | 8.31M | -11.29% | 51,733 | - |
| 42 | ADVB | Advanced Biomed Inc. | 8.24M | 4.75% | 12,705 | - |
| 43 | NDRA | ENDRA Life Sciences Inc. | 5.99M | -6.35% | 12,917 | - |
| 44 | ISPC | iSpecimen Inc. | 3.79M | -3.30% | 135,210 | 1.03M |
| 45 | BIAF | bioAffinity Technologies, Inc. | 3.76M | -1.60% | 141,997 | 5.66M |